HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Double-blind method of using solcoseryl ophthalmic gel and 2,4% cysteine in ophthalmic gel in patients with chronic recurrent keratitis and keratitis sicca].

Abstract
A double blind study with Solcoseryl compounds in ophthalmic gel and with 2.4% cystein in ophthalmic gel was performed in the period 1985-1988; it was used in 18 cases: with chronic recurrent keratitis (11 patients) and sicca keratitis (7 patients). Observed was the influence of these compounds on the epithelialization of the cornea, on the improvement of corneal transparency, the diminutation of the troubles connected with dessication of the eye in sicca keratitis. In spite of the small number of cases the observations were interesting. In patients with a chronic recurrent keratitis the influence of both compounds showed to be beneficial for the condition of the cornea. In patients with keratitis sicca one could observe a better tolerance of the Solcoseryl ophthalmic gel which could be applied for a longer period in comparison with cystein in gel.
AuthorsK M Krzystkowa, M Hydzikowa, R Szpytma
JournalKlinika oczna (Klin Oczna) Vol. 93 Issue 6 Pg. 162-3 (Jun 1991) ISSN: 0023-2157 [Print] Poland
Vernacular TitlePodwójna ślepa próba z zastosowaniem preparatów solcoseryl zel oczny i 2.4% cysteiny w zelu ocznym u chorych z keratitis chronica recidivans i keratitis sicca.
PMID1942917 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Gels
  • Actihaemyl
  • Cysteine
Topics
  • Actihaemyl (administration & dosage)
  • Chronic Disease
  • Cysteine (administration & dosage)
  • Double-Blind Method
  • Gels
  • Humans
  • Keratitis (drug therapy)
  • Keratoconjunctivitis Sicca (drug therapy)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: